GlassScriptPhysician profile
Pasquale Montesano
NPI 1992814743
$191,541.23
in general payments reported to CMS, 2019-2025
18 companies · $8,551 in 2025
The $8,551 reported for 2025 was more than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
See the full distribution for Orthopaedic Surgery of the Spine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $65K · 2020: $45K · 2021: $28K · 2022: $26K · 2023: $15K · 2024: $3,922 · 2025: $8,551.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $22K · Travel and Lodging: $3,347 · Food and Beverage: $1,447.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $22,492.38 |
| Travel and Lodging | $3,347.16 |
| Food and Beverage | $1,447.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Precision Spine, INC. | $167,223.24 | 2019-2023 | |
| Mirus, LLC | $11,652.21 | 2020-2025 | Europa Pedicle Screw System |
| Solco Biomedical Corporation | $3,750.00 | 2020-2021 | |
| Aegis Spine, INC. | $2,519.60 | 2019 | |
| Spineart USA INC | $2,253.03 | 2023 | Perla C, Scarlet Al-T |
| Alphatec Spine, INC | $2,240.89 | 2024 | Other - Miscellaneous, Lif, Solus Alif |
| Spinal Elements, INC. | $692.93 | 2019 | |
| Orthofix Medical, INC. | $489.56 | 2021-2025 | Newbridge, M6-C, Explorer To |
| Stryker Corporation | $131.51 | 2023 | Monterey Al |
| Nevro Corp. | $124.50 | 2022 | |
| Acuity Surgical Devices, LLC | $108.28 | 2022 | |
| Depuy Synthes Sales INC. | $96.59 | 2019 | |
| Abbott Laboratories | $88.13 | 2022 | |
| Silony Medical Corp. | $84.94 | 2019 | |
| Integrity Implants INC. | $37.63 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $18.44 | 2021 | |
| Genentech USA, INC. | $16.17 | 2020 | |
| Omeros Corporation | $13.58 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pasquale Montesano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.